These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27345399)

  • 1. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
    Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
    Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.
    Li SS; Xu LZ; Zhou W; Yao S; Wang CL; Xia JL; Wang HF; Kamran M; Xue XY; Dong L; Wang J; Ding XD; Bella L; Bugeon L; Xu J; Zheng FM; Dallman MJ; Lam EWF; Liu Q
    Carcinogenesis; 2017 Oct; 38(11):1092-1103. PubMed ID: 28968743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.
    Li S; Jin Z; Song X; Ma J; Peng Z; Yu H; Song J; Zhang Y; Sun X; He M; Yu X; Jin F; Zheng A
    Mol Carcinog; 2024 Jun; 63(6):1117-1132. PubMed ID: 38421204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
    Zhu P; He F; Hou Y; Tu G; Li Q; Jin T; Zeng H; Qin Y; Wan X; Qiao Y; Qiu Y; Teng Y; Liu M
    Oncogene; 2021 Mar; 40(9):1609-1627. PubMed ID: 33469161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
    Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc.
    Liu H; Zhao WL; Wang JP; Xin BM; Shao RG
    Acta Pharmacol Sin; 2018 Aug; 39(8):1347-1358. PubMed ID: 29283175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1.
    Sun X; Jiang S; Liu J; Wang H; Zhang Y; Tang SC; Wang J; Du N; Xu C; Wang C; Qin S; Zhang J; Liu D; Zhang Y; Li X; Wang J; Dong J; Wang X; Xu S; Tao Z; Xu F; Zhou J; Wang T; Ren H
    Oncotarget; 2015 Oct; 6(32):32944-54. PubMed ID: 26460550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.
    Li Y; Francia G; Zhang JY
    Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA let-7b in breast cancer.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Biochem; 2018 Jun; 119(6):4570-4580. PubMed ID: 29236319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of triple negative breast cancer by down-regulating the expression of c-Myc.
    Du J; Fan JJ; Dong C; Li HT; Ma BL
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5301-5314. PubMed ID: 31298382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMELESS contributes to the progression of breast cancer through activation of MYC.
    Chi L; Zou Y; Qin L; Ma W; Hao Y; Tang Y; Luo R; Wu Z
    Breast Cancer Res; 2017 May; 19(1):53. PubMed ID: 28464854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.